<DOC>
	<DOCNO>NCT02975739</DOCNO>
	<brief_summary>The main objective establish feasibility 166-Holmium microspheres intratumoral injection oral squamous cell carcinoma ( OSCC ) tongue . Participants receive intratumoral injection low radioactive 166-Holmium microspheres follow surgical resection</brief_summary>
	<brief_title>Feasibility Holmium-166 Micro Brachytherapy Head Neck Tumors</brief_title>
	<detailed_description>166-Holmium microspheres poly lactic acid microspheres currently use selective internal radiation therapy . These microspheres emit beta radiation . The majority radiation dose absorb within 3.2 mm maximum penetration tissue 9 mm . Therefore result high local tumor ablative dose minimal dose healthy adjacent tissue .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>1 . Patients must give write informed consent . 2 . Aged 18 year . 3 . Confirmed histological diagnosis squamous cell carcinoma tongue . 4. primary tumor , regional node , metastasis ( TNM ) stage T12 Nx M0 . 5 . Eligible local surgery curative intent . 6 . World Health Organization ( WHO ) Performance status 02 . 1 . Previous oncologic surgery and/or external beam radiation therapy tongue oral floor . 2 . Major surgery ( Orofacial ) within past 4 week incompletely heal surgical incision start study therapy . 3 . Any unresolved toxicity great National Cancer Institute ( NCI ) , Common Terminology Criteria Adverse Events ( CTCAE version 4.03 ) grade 2 previous anticancer therapy . 4 . Pregnancy nursing ( woman childbearing potential ) . 5 . Patients suffer psychic disorder make comprehensive judgment impossible , psychosis , hallucination and/or depression . 6 . Previous enrolment present study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Intratumoral</keyword>
	<keyword>Tongue</keyword>
	<keyword>Microspheres</keyword>
</DOC>